Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Trading Cabana -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Podsiadlik who wrote (5503)	5/18/2009 11:35:43 AM
From: RockyBalboa	Read Replies (1) \| Respond to of 6370

It makes sense anyways, as for the 1.65 warrants, I would do the same; and start hedging as close as possible to the warrant strike price which maximises the profit. Well unless the "investors" know more than we do. Since even the FDA seems to follow the bailout politics - by approving weak drugs like fanapt from VNDA it can throw smaller biotechs a lifeline... nothing can be ruled out this time. Remember Cygnus which got something approved in the gung-ho days in 2000. Stock doubled to 20, from 10 only to fall to pennies later as the approval didnt make then any money.